Groupe PARIMA
Premium PartnerIs this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Groupe PARIMA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Canada
Founded:1992
Employees:1,879
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Groupe PARIMA Inc.
4450 Cousens, Montreal, Quebec H, 4S 1X6
Site Capabilities
3 capabilitiesLABEL
MANUFACTURE
PACK
Regulatory Approvals
Drug Approval 7CICD6
PMDA · #APR-SFIKS8CK · 2018-07-01
Drug Approval 1A7NOJ
FDA · #APR-X4VCTP2K · 2018-06-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-3IQTQLQH
Issued: 2020-01-07
Expires: 2025-05-27
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-FMW3ERK7
Issued: 2020-02-09
Expires: 2025-03-16
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-MEPPUQ5H
Issued: 2020-01-16
Expires: 2025-07-17
Loading CDMO intelligence...
Key facts about Groupe PARIMA
- Groupe PARIMA is headquartered in Canada.
- Groupe PARIMA was founded in 1992.
- Groupe PARIMA has 1,879 employees.
- Groupe PARIMA has one manufacturing site listed on CDMO Hub, in Montreal, Canada.
- Groupe PARIMA's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Groupe PARIMA
Directory pages this company appears in, each with the full list of matching manufacturers.